Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Corporate Overview
Overview
Management Team
Board of Directors
Social Responsibility
NPC Blog
Presentations
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma
Name:
Email:

Yes, in addition to e-alerts, please sign me up to receive Nutra Pharma Blog postings via email.

Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Social Responsibility

Nutra Pharma is proud to be involved with the following non-profit social healthcare organizations:

Stop TB Partnership
   
The Stop TB Partnership was established in 2000 to realize the goal of eliminating TB as a public health problem and, ultimately, to obtain a world free of TB. It comprises a network of international organizations, countries, donors from the public and private sectors, governmental and nongovernmental organizations and individuals that have expressed an interest in working together to achieve this goal.
   
   
AIDS Care Watch
   
The AIDS-Care-Watch Campaign is a global initiative with the goal of reducing the number of HIV-related deaths. The campaign has over 400 non-governmental and civil society partners throughout the world, including the International Community of Women Living with HIV/AIDS and the World AIDS Campaign.
   
   
Health on the Net Foundation
   
The HON Foundation is a Non-Governmental Organization, internationally known for its pioneering work in the field of health information ethics, notably for the establishment of its code of ethical conduct, the HONcode. We comply with the HONcode standard for health trust worthy information: verify here.
 
Quick Nav
 
Recent News
August 14, 2008
Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)


August 6, 2008
Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)


August 1, 2008
August 2008 Shareholder Letter from Chairman and CEO Rik J. Deitsch


 
 
Announcements
Click Here for an Update on the Phase IIb Clinical Trial Data.
 
 
NPC
Privacy Policy